España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Sunshine Biopharma
Insider Buying: Sunshine Biopharma Inc. (NASDAQ: SBFM) Chief Financial Officer Purchases Shares
Sponsored
Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed
Sponsored
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
Sponsored
Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed
Sponsored
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
Sponsored
Sunshine Biopharma's Essential 9 Supplement Marks The Pharma Company's Entry Into $152 Billion Dietary Supplement Market
Sponsored
Pharmaceutical Companies Report Gearing Up To Combat COVID Variants This Fall
Sponsored
Sunshine Biopharma's Essential 9 Supplement Marks The Pharma Company's Entry Into $152 Billion Dietary Supplement Market
Sponsored
Pharmaceutical Companies Report Gearing Up To Combat COVID Variants This Fall
Sponsored
Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months
Sponsored
Sunshine Biopharma Extends Aid To The University Of Arizona For Anti-Coronavirus Collaborative Research
Sponsored
Read More...
Sunshine Biopharma Recent News
SUNSHINE BIOPHARMA INCREASES SUPPORT FOR ANTI-CORONAVIRUS COLLABORATIVE RESEARCH WITH THE UNIVERSITY OF ARIZONA
Montreal, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc.
Sponsored
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
Image provided by Pexels
Sponsored
Sunshine Biopharma Prepares For IND Study Of Novel Cancer Drug That It Expects Could Beat Multidrug-Resistant Cancer
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Sponsored
Sunshine Biopharma Boasts Of Management Team With Wealth Of Medical And Scientific Knowledge
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Sponsored
Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research
Photo credit: Patent application by Nick Youngson CC BY-SA 3.0
Sponsored
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc.
Sponsored
EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments
Sunshine Biopharma Inc. (NASDAQ: SBFM) might be living the concept of being in the right place at the right time.
Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells
Photo by Angiola Harry on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Sponsored
Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development
Image provided by the National Cancer Institute on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Sponsored
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market
Photo by Scott Graham on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Sponsored
Sunshine Biopharma, Inc. Announces Closing of $8 Million Public Offering and Uplisting to the Nasdaq Capital Market
MONTREAL, Canada, Feb.
Sponsored